Full results of the SURPASS-1 clinical trial were presented at the American Diabetes Association’s 81st Scientific Sessions.

Patients presenting with an acute myocardial infarction during the start of the COVID-19 pandemic faced delays in care and a higher risk of developing heart failure.

Researchers have developed a new risk score that outperforms previous techniques. 

The analysis, published in European Heart Journal Open, also included a look at how COVID-19 may affect these numbers going forward. 

Myocardial fibrosis was more common among people with a confirmed HIV diagnosis, the authors found.

The patient, a 78-year-old female, began showing signs of a negative reaction within 20 hours. 

The study's authors called for additional research in this area, noting that it may be beneficial to screen all heart failure patients for cancer. 

In a new statement, the CDC, American Heart Association and several other healthcare organizations highlighted the continued importance of vaccination. 

The approval includes patients as young as three months old. 

The study's authors examined data from more than 21,000 participants.